Intertek Group Plc | Annual Report 2017

Total Page:16

File Type:pdf, Size:1020Kb

Intertek Group Plc | Annual Report 2017 THE GLOBAL TQA EXPERTS ANNUAL REPORT 2017 OVERVIEW INTERTEK AT A GLANCE OUR SERVICES As the global pioneers of a fully integrated Assurance, Testing, Inspection and Certification ('ATIC') solution, we offer our clients an end-to-end systemic Total Quality Assurance ('TQA') value proposition. In doing so, we help customers operate more safely, more effectively and with greater peace of mind. Read more on our services on page 10 ASSURANCE TESTING OUR SECTORS Our organisational structure ensures our people’s expertise is concentrated in the markets where customers need our direct support. With business lines structured in the three sectors of Products, Trade and Resources, we focus on attractive growth and margin PRODUCTS sectors where we can add most value. Read more in our operating REVENUE reviews on pages 22 to 29 £1,625m ADJUSTED OPERATING PROFIT £350m STATUTORY OPERATING PROFIT £336m OUR HISTORY 1885 Caleb Brett 1896 Thomas 1911 Virginius 1925 SEMKO (the The Intertek story features some founds his cargo Edison sets up Daniel Moody Swedish Electronic of history’s most prominent Quality certification the Lamp Testing founds the Moody Equipment Control Assurance pioneers. Today, our business in the UK Bureau in the US. International oil Office) is founded population of innovative and (This later becomes and gas testing passionate experts continues this 1888 Milton 1927 The Charles the Electrical and certification tradition as we introduce our unique Hersey establishes Warnock Company Testing Laboratories business in the US Total Quality Assurance value his chemical is created in or ETL – a mark proposition to companies across testing lab in Canada to inspect that Intertek still the world. Canada steel products applies today) INSPECTION CERTIFICATION TRADE RESOURCES REVENUE REVENUE £648m £496m ADJUSTED OPERATING ADJUSTED OPERATING PROFIT PROFIT £89m £29m STATUTORY OPERATING STATUTORY OPERATING PROFIT PROFIT £83m £4m 1973 Labtest 1987 Inchcape 1994 ITS acquires 2002 Intertek 2015 Intertek 2017 Intertek is established Testing Services SEMKO lists on the buys the acquires KJ Tech in Hong Kong, (ITS, the future London Stock PSI building and and Acumen 2002 Inchcape initially to focus Intertek) is Exchange construction Security sells ITS to on testing founded and business Charterhouse 2009 Intertek textiles completes Development enters the FTSE 2016 Intertek the purchase Capital. ITS is 100 index acquires FIT-Italia of Caleb Brett renamed Intertek and EWA-Canada, 2011 Intertek 1989 ITS enters and enters a joint acquires Moody the Chinese market venture with ABC International Analitic in Mexico OVERVIEW FINANCIAL HIGHLIGHTS • Group revenue growth of: +3.0% at • Strong diluted EPS growth: Continued progress in constant currency rates, +7.9% at adjusted +10.4% at constant rates, revenue, margin and actual rates +14.3% at actual rates; statutory +12.4% at actual rates cash reflecting the • Solid organic revenue growth at constant rates of 2.1%: Products +5.5%, • Full year dividend per share of 71.3p, Group’s performance Trade +3.0%, Resources -8.6% an increase of 14.3% management discipline • Portfolio strength and performance • Free adjusted cash flow of £342m, management discipline driving margin +7.4% year on year focused on margin- progression: adjusted +110bps at • Free statutory cash flow of £309m, constant rates, +90bps at actual rates accretive revenue +10.2% year on year growth and cash • Adjusted operating profit of £468m, an increase of 14.2% at actual rates and conversion. 10.0% at constant rates • Statutory operating profit of £423m, an increase of 14.4% at actual rates and 10.3% at constant rates REVENUE (£m) OPERATING PROFIT1,2 (£m) +7.9 % +14.2% +14.4% 2017 2,769 2017 423 468 2016 2,567 2016 370 410 DILUTED EARNINGS PER SHARE1 (pence) FREE CASH FLOW1 (£m) +14.3% +12.4% +7.4% +10.2% 2017 176.3 191.6 2017 309 342 2016 156.8 167.7 2016 280 318 DIVIDEND PER SHARE3 (pence) RETURN ON INVESTED CAPITAL AT CONSTANT CURRENCY2 (%) +14.3% +280bps 2017 71.3 2017 26.7 2016 62.4 2016 23.9 2017 Adjusted 2017 Statutory 2016 Adjusted 2016 Statutory 1. Adjusted operating profit, adjusted diluted earnings per share (‘EPS’) and adjusted free cash flow, which are non-GAAP measures, are stated before Separately Disclosed Items, which are described in note 3 to the financial statements. Reconciliations between statutory and adjusted measures, as well as Return on Invested Capital and cash conversion, are shown in the Financial review on pages 38 to 43. 2. Definitions of the above metrics and constant currency are set out on page 30. 3. Dividend per share for 2017 is based on the interim dividend paid of 23.5p (2016: 19.4p) plus the proposed final dividend of 47.8p (2016: 43.0p). OVERVIEW OVERVIEW Financial Highlights IFC We are leading the Intertek at a Glance IFC STRATEGIC REPORT industry with our Our 5x5 Strategy 2 Our Sustainability Goals 4 Our Global Network 6 end-to-end systemic Market Opportunities 8 Our TQA value proposition 9 Our Services 10 Total Quality Assurance Our Experts 11 Life Cycle of a Lightbulb 12 Chief Executive Officer’s review 14 ('TQA') value proposition Executive Management Team 20 Operating reviews 22 KPIs – Measuring our strategy 30 Principal risks and uncertainties and of Assurance, Testing, Long-term Viability statement 32 Financial review 38 Sustainability and Corporate Social Inspection and Responsibility 44 DIRECTORS’ REPORT Certification solutions, Chairman’s introduction 62 Corporate Governance 64 Board of Directors 68 delivered across the Nomination Committee 72 Audit Committee 75 Remuneration report 81 world by our global Other statutory information 99 Statement of Directors’ responsibilities 102 FINANCIAL STATEMENTS TQA Experts. Contents 103 Read more in the CEO Review on page 14 Consolidated primary statements 104 Notes to the financial statements 109 Intertek Group plc – Company 152 primary statements and notes OTHER Independent Auditor’s Report 157 Shareholder and corporate information 164 STRATEGIC REPORT OUR 5X5 STRATEGY DIFFERENTIATED FOR GROWTH WITH OUR 5X5 STRATEGY OUR GOALS Our 5x5 strategy aims to move the Company’s • Fully engaged employees working in centre of gravity towards high-growth and high- a safe environment margin areas of industries across the world. • Superior customer service in Assurance, Testing, Inspection and Certification • Margin-accretive revenue growth based on GDP+ organic growth • Strong cash conversion from operations • Accretive, disciplined capital allocation policy OUR PURPOSE Bringing quality and safety to life. OUR VISION To be the world’s most trusted partner for Quality Assurance. OUR TQA CUSTOMER PROMISE Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely. OUR CUSTOMER-CENTRIC ORGANISATION Our decentralised organisational model places our people's talents, commitment and ambition to succeed directly where our clients need them most – in the markets where they work and live. Then, by supporting all our people with shared operating principles across our global footprint, we empower them to It’s exciting to work with react quickly to the constantly evolving clients on innovative products, ATIC needs of those clients. especially for new energy That drives the ultimate Intertek sources, renewables, and smart differentiator that’s at the heart of our grids where we can be part of drive for global growth – our unique ability creating a better future." to deliver the Total Quality Assurance solutions our clients demand with precision, pace and passion. Sarah Linn Global Marketing Director, Electrical & Network Assurance UK 2 INTERTEK GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 STRATEGIC REPORT • Increase existing account penetration • Prioritised business lines, geographies and • Drive ATIC cross-selling • Build customer loyalty service areas • Business development and win new customers • Invest in areas with with new accounts • TQA customer service good growth and good delivered consistently margin prospects • Continuous improvement to • Innovative ATIC solutions • Disciplined resource, capital and people drive productivity • Position Intertek as allocation • Best-in-class the leading Quality management to Assurance provider reduce span of • Build brand awareness performance across sectors and EFFECTIVE SALES • Eliminate non- geographies STRATEGY essential costs – • Compelling Total GROWTH AND facilities/offices/ SUPERIOR Quality Assurance MARGIN- processes/ CUSTOMER brand positioning ACCRETIVE purchasing SERVICE PORTFOLIO EGIC TRAT PRIO 5 S RI R TI U ES O STRONG BRAND OPERATIONAL PROPOSITION EXCELLENCE 5x5 DIFFERENTIATED STRATEGY FOR GROWTH LIVING OUR DELIVERING CUSTOMER- SUSTAINABLE CENTRIC RESULTS CULTURE O U S R ER 5 S BL TRATEGIC ENA DISCIPLINED • Strong entrepreneurial ENERGISING • Sustainable growth PERFORMANCE culture OUR PEOPLE for customers MANAGEMENT and shareholders • Customer-centric culture SUPERIOR • Importance of sustainability for • Engagement at TECHNOLOGY the community all levels • Right balance between • Performance management • Invest in capability performance with financial and • Aligned reward system and sustainability non-financial metrics • Promote internal growth • Forecast and review processes focused • Improve customer on margin-accretive experience revenue growth with strong cash conversion • Leverage back-office synergies • Upgrade business intelligence system INTERTEK GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 3 STRATEGIC REPORT OUR SUSTAINABILITY
Recommended publications
  • RSPO Letterhead
    EB 02-08 Minutes of Executive Board Meeting Date : 27 May 2008 Venue : Teleconference Start time : 0800 (UK), 0900 (Nl), 1400 (Ina), 1500(My) Attendees: Apologies: 1. Derom Bangun ( GAPKI) 2. Paul Norton (HSBC Malaysia) 1. Johann Zueblin (Migros) 3. Ian McIntosh (AAK) 2. Tim Stephenson ( AAK) 4. Christophe Liebon (Intertek) 3. Simon Lord ( Kulim Malaysia Bhd 5. Don Grubba ( IOI) ) 6. Johan Verburg (Oxfam) 4. Tony Lass ( Cadbury 7. Jan Kees Vis ( Unilever) – Chair Schweppes) 8. Chew Jit Seng (MPOA) 5. Fitrian Adrianshah (WWF- 9. Mamat Salleh (MPOA) Indonesia) 10.MR Chandran (RSPO EB Advisor) 6. Matthias Diemer ( WWF – 11.Thomas Barano ( WWF- Indonesia) Switzerland) 12.Robert Keller ( MIGROS) 7. Mohd Nor Kailany ( Felda) 13.Rudy Lumuru ( Sawit Watch) 8. Samantha Lacey ( CIS) 14.Chong Wei Kwang ( HSBC Malaysia) 9. Darrel Webber ( WWF- Malaysia) 15.Vengeta Rao (VR, Secretariat) 10.Didiek Hajar Gunadi (GAPKI) 16.Desi Kusumadewi ( RILO) AGENDA 1. Introduction and RSPO Antitrust laws 2. Confirmation of minutes of EB 01-08 3. Secretariat 3.1 Accounts & finances 3.1.1 Update on RSPO Accounts to end March 2008 3.1.2 Update on RSPO Sdn Bhd Accounts to end March 2008 3.2 Secretariat updates 3.2.1 Update from Secretary General including RILO matters 4. Membership 4.1 Outstanding/defaulting RSPO Members 4.2 Grievances 4.3 Outstanding Membership applications 4.4 Revised membership application procedures and flowchart 5. Executive Board matters 5.1 Welcome New Members / Alternates / Changes 5.2 EB Retailers seat 5.3 Approval of Ina – NI 5.4 Approval of CBs – PT Mutu Agung (Ina), PT TUV Nord (Ina) 5.5 RT6 theme, delegates fees, exhibition rentals and sponsorships 5.6 RSPO FAQ on C7.3 – cut off date 6.
    [Show full text]
  • The T.I.C. Annual Review 2018
    Presented at the Fifty-ninth General Assembly of the Tantalum-Niobium International Study Center (T.I.C.) Kigali, Rwanda, 14th-17th October 2018 Contents 5 President’s Letter 6 About the T.I.C. 7 Executive Committee, Subteams and Officers 9 Director’s Report 2017-2018 14 Who is the T.I.C.? 15 Presidents of the Association 17 General Assemblies and Symposia 19 Antitrust Compliance Policy 21 Speakers’ Biographies 25 Directory of Members 41 Applying for T.I.C. Membership 42 Benefits of T.I.C. Membership Tantalum-Niobium International Study Center (T.I.C.) Address: Chaussée de Louvain 490, 1380 Lasne, Belgium Phone: +32 2 649 51 58 Skype: T.I.C._Director Email: [email protected] Website: www.TaNb.org VAT no.: BE0414.408.447 Legal status: The T.I.C. is an AISBL under Belgian law. Legal counsel: Jones Day 4 Rue de la Régence, 1000 Brussels, Belgium https://www.jonesday.com/brussels/ Accountant: Bofidi Brussels Tervurenlaan 32, 1040 Brussels, Belgium http://www.bofidi.eu/ Auditor: JCB RE Avenue des Héros 41, 1160 Brussels, Belgium © Tantalum-Niobium International Study Center (T.I.C.) 2018 3 President’s Letter Dear Fellow Members and Friends, It is my pleasure to welcome you to the 2018 Annual Review, published to mark our Fifty-ninth General Assembly in Kigali, Rwanda. Hopefully, you will have noticed the beginning of the changes to our organization that I discussed in Vancouver in 2017. This Annual Review highlights some of the initiatives we have had underway since our last meeting. We are seeking to improve our industry for our members and guide issues that impact our businesses and activities relating to tantalum and niobium.
    [Show full text]
  • Dec 2004 Current List
    Fighter Opponent Result / RoundsUnless specifiedDate fights / Time are not ESPN NetworkClassic, Superbouts. Comments Ali Al "Blue" Lewis TKO 11 Superbouts Ali fights his old sparring partner Ali Alfredo Evangelista W 15 Post-fight footage - Ali not in great shape Ali Archie Moore TKO 4 10 min Classic Sports Hi-Lites Only Ali Bob Foster KO 8 21-Nov-1972 ABC Commentary by Cossell - Some break up in picture Ali Bob Foster KO 8 21-Nov-1972 British CC Ali gets cut Ali Brian London TKO 3 B&W Ali in his prime Ali Buster Mathis W 12 Commentary by Cossell - post-fight footage Ali Chuck Wepner KO 15 Classic Sports Ali Cleveland Williams TKO 3 14-Nov-1966 B&W Commentary by Don Dunphy - Ali in his prime Ali Cleveland Williams TKO 3 14-Nov-1966 Classic Sports Ali in his prime Ali Doug Jones W 10 Jones knows how to fight - a tough test for Cassius Ali Earnie Shavers W 15 Brutal battle - Shavers rocks Ali with right hand bombs Ali Ernie Terrell W 15 Feb, 1967 Classic Sports Commentary by Cossell Ali Floyd Patterson i TKO 12 22-Nov-1965 B&W Ali tortures Floyd Ali Floyd Patterson ii TKO 7 Superbouts Commentary by Cossell Ali George Chuvalo i W 15 Classic Sports Ali has his hands full with legendary tough Canadian Ali George Chuvalo ii W 12 Superbouts In shape Ali battles in shape Chuvalo Ali George Foreman KO 8 Pre- & post-fight footage Ali Gorilla Monsoon Wrestling Ali having fun Ali Henry Cooper i TKO 5 Classic Sports Hi-Lites Only Ali Henry Cooper ii TKO 6 Classic Sports Hi-Lites Only - extensive pre-fight Ali Ingemar Johansson Sparring 5 min B&W Silent audio - Sparring footage Ali Jean Pierre Coopman KO 5 Rumor has it happy Pierre drank before the bout Ali Jerry Quarry ii TKO 7 British CC Pre- & post-fight footage Ali Jerry Quarry ii TKO 7 Superbouts Ali at his relaxed best Ali Jerry Quarry i TKO 3 Ali cuts up Quarry Ali Jerry Quarry ii TKO 7 British CC Pre- & post-fight footage Ali Jimmy Ellis TKO 12 Ali beats his old friend and sparring partner Ali Jimmy Young W 15 Ali is out of shape and gets a surprise from Young Ali Joe Bugner i W 12 Incomplete - Missing Rds.
    [Show full text]
  • Intertek Annual Report 2008
    FC1 Intertek Group plc Annual Report 2008 Report Annual Bringing competitive advantage to business Annual Report 2008 IFC2 Contents 01 Financial Highlights 02 At a Glance 04 Chairman’s Statement Directors’ Report – Business Review 06 Chief Executive Officer’s Review 09 Operating Review 23 Chief Operating Officer’s Review 24 Financial Review 28 Risks and Uncertainties Directors’ Report – Governance 32 Board of Directors 34 Intertek Operations Committee 36 Corporate Governance Report 42 Remuneration Report 56 Other Statutory Information 58 Statement of Directors’ Responsibilities 59 Corporate Social Responsibility Report Financial Statements 66 Independent Auditors’ Report 68 Consolidated Income Statement 69 Consolidated Balance Sheet 70 Consolidated Statement of Cash Flows 71 Consolidated Statement of Recognised Income and Expense 72 Notes to the Financial Statements 112 Intertek Group plc Company Balance Sheet 113 Notes to the Company Financial Statements Shareholder Information 116 Corporate and Shareholder Information 117 Financial Calendar and Contact Information Cautionary statement This Annual Report contains certain forward- looking statements with respect to the financial condition, results, operations and business of Intertek Group plc. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking
    [Show full text]
  • In February 2013, Glaxosmithkline (GSK) Announced a Commitment To
    In February 2013, GlaxoSmithKline (GSK) announced a commitment to further clinical transparency through the public disclosure of GSK Clinical Study Reports (CSRs) on the GSK Clinical Study Register. The following guiding principles have been applied to the disclosure: Information will be excluded in order to protect the privacy of patients and all named persons associated with the study Patient data listings will be completely removed* to protect patient privacy. Anonymized data from each patient may be made available subject to an approved research proposal. For further information, please see the Patient Level Data section of the GSK Clinical Study Register. Aggregate data will be included; with any direct reference to individual patients excluded *Complete removal of patient data listings may mean that page numbers are no longer consecutively numbered Document Name RH205051 Synopsis Type Version Document Identifier Effective Date eldo_controlled 1.0; CURRENT; Most-Recent; Effective 090032d580d18c62 Reason For Issue Synopsis Report Study Number 205051 Study Title A Study to Investigate the Ant imicrobial Activity of two Test toothpastes in a Plaque Glycolysis and Regrowth Model. Test Product(s) Test toothpaste containing 0.6% w/w zinc chloride and 0.1% w/w isopropylmethylpheno l (IPMP) and 1426ppm fluoride as sodium fluoride. Indication Ant imicrobial activity Phase Not Applicable Authors: Clinical Operations PPD , HND BioStatistics PPD , BSc, MSc Clinical Research PPD , BS Approvers: Clinical Operations PPD , PhD BioStatistics PPD , BSc, CStat Clinical Research PPD , BSc, MSc, CStat Copyright: GlaxoSmithKline. An unpublished work subject to trade secret protection. This work contains confidential and proprietary information of GlaxoSmithKline and should not be copied, circulated, or distributed to persons not employed by GlaxoSmithKline unless specifically authorized.
    [Show full text]
  • In Re CPI Card Group Inc. Securities Litigation 16-CV-04531-U.S
    US District Court Civil Docket as of September 18, 2019 Retrieved from the court on September 18, 2019 U.S. District Court Southern District of New York (Foley Square) CIVIL DOCKET FOR CASE #: 1:16-cv-04531-LAK-DCF IN RE CPI CARD GROUP INC. SECURITIES LITIGATION Date Filed: 06/15/2016 Assigned to: Judge Lewis A. Kaplan Date Terminated: 02/25/2019 Referred to: Magistrate Judge Debra C. Freeman Jury Demand: Plaintiff Cause: 15:78j(b)ss Stockholder Suit Nature of Suit: 850 Securities/Commodities Jurisdiction: Federal Question Lead Plaintiff Alex Stewart represented by Alfred Louis Fatale , III Labaton & Sucharow LLP (NYC) 140 Broadway New York, NY 10005 (212)-818-0477 Fax: (212)-818-0477 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED Eric David Gottlieb Labaton & Sucharow LLP (NYC) 140 Broadway New York, NY 10005 (212) 907-0623 Fax: (212) 883-7019 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED Joel H. Bernstein Labaton Sucharow, LLP 140 Broadway New York, NY 10005 212-907-0869 Fax: 212-883-7069 Email: [email protected] TERMINATED: 09/04/2018 LEAD ATTORNEY ATTORNEY TO BE NOTICED Jonathan Gardner Labaton Sucharow, LLP 140 Broadway New York, NY 10005 212-907-0839 Fax: 212-818-0477 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED Ross Michael Kamhi Labaton & Sucharow LLP (NYC) 140 Broadway, 34th Floor New York, NY 10005 (212) 907-0700 Fax: (212) 818-0477 Email: [email protected] LEAD ATTORNEY ATTORNEY TO BE NOTICED Michael P. Canty Labaton Sucharow 140 Broadway New York, NY 10005 (212)-907-0863 Fax: (212)-883-7063 Email: [email protected] ATTORNEY TO BE NOTICED Michael Walter Stocker Labaton & Sucharow LLP (NYC) 140 Broadway, 34th Floor New York, NY 10005 (212) 907-0882 Fax: (212) 883-7082 Email: [email protected] TERMINATED: 03/20/2018 Nicole M.
    [Show full text]
  • Wolters Kluwer Governance Roadshow
    Wolters Kluwer Governance Roadshow Selection & Remuneration Committee of the Supervisory Board of Wolters Kluwer September, 2020 Governance Roadshow, September 2020 1 Forward-looking statements This presentation contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions, conditions in the markets in which Wolters Kluwer is engaged, behavior of customers, suppliers and competitors, technological developments, the implementation and execution of new ICT systems or outsourcing, legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions and divestments. In addition, financial risks, such as currency movements, interest rate fluctuations, liquidity and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Growth rates are cited in constant currencies unless otherwise noted.
    [Show full text]
  • Annex 1: Parker Review Survey Results As at 2 November 2020
    Annex 1: Parker Review survey results as at 2 November 2020 The data included in this table is a representation of the survey results as at 2 November 2020, which were self-declared by the FTSE 100 companies. As at March 2021, a further seven FTSE 100 companies have appointed directors from a minority ethnic group, effective in the early months of this year. These companies have been identified through an * in the table below. 3 3 4 4 2 2 Company Company 1 1 (source: BoardEx) Met Not Met Did Not Submit Data Respond Not Did Met Not Met Did Not Submit Data Respond Not Did 1 Admiral Group PLC a 27 Hargreaves Lansdown PLC a 2 Anglo American PLC a 28 Hikma Pharmaceuticals PLC a 3 Antofagasta PLC a 29 HSBC Holdings PLC a InterContinental Hotels 30 a 4 AstraZeneca PLC a Group PLC 5 Avast PLC a 31 Intermediate Capital Group PLC a 6 Aveva PLC a 32 Intertek Group PLC a 7 B&M European Value Retail S.A. a 33 J Sainsbury PLC a 8 Barclays PLC a 34 Johnson Matthey PLC a 9 Barratt Developments PLC a 35 Kingfisher PLC a 10 Berkeley Group Holdings PLC a 36 Legal & General Group PLC a 11 BHP Group PLC a 37 Lloyds Banking Group PLC a 12 BP PLC a 38 Melrose Industries PLC a 13 British American Tobacco PLC a 39 Mondi PLC a 14 British Land Company PLC a 40 National Grid PLC a 15 BT Group PLC a 41 NatWest Group PLC a 16 Bunzl PLC a 42 Ocado Group PLC a 17 Burberry Group PLC a 43 Pearson PLC a 18 Coca-Cola HBC AG a 44 Pennon Group PLC a 19 Compass Group PLC a 45 Phoenix Group Holdings PLC a 20 Diageo PLC a 46 Polymetal International PLC a 21 Experian PLC a 47
    [Show full text]
  • Ftse4good UK 50
    2 FTSE Russell Publications 19 August 2021 FTSE4Good UK 50 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.81 UNITED GlaxoSmithKline 5.08 UNITED Rentokil Initial 0.67 UNITED KINGDOM KINGDOM KINGDOM Anglo American 2.56 UNITED Halma 0.74 UNITED Rio Tinto 4.68 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.36 UNITED HSBC Hldgs 6.17 UNITED Royal Dutch Shell A 4.3 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.56 UNITED InterContinental Hotels Group 0.64 UNITED Royal Dutch Shell B 3.75 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 8.25 UNITED International Consolidated Airlines 0.47 UNITED Schroders 0.28 UNITED KINGDOM Group KINGDOM KINGDOM Aviva 1.15 UNITED Intertek Group 0.65 UNITED Segro 0.95 UNITED KINGDOM KINGDOM KINGDOM Barclays 2.1 UNITED Legal & General Group 1.1 UNITED Smith & Nephew 0.99 UNITED KINGDOM KINGDOM KINGDOM BHP Group Plc 3.2 UNITED Lloyds Banking Group 2.39 UNITED Smurfit Kappa Group 0.74 UNITED KINGDOM KINGDOM KINGDOM BT Group 1.23 UNITED London Stock Exchange Group 2.09 UNITED Spirax-Sarco Engineering 0.72 UNITED KINGDOM KINGDOM KINGDOM Burberry Group 0.6 UNITED Mondi 0.67 UNITED SSE 1.13 UNITED KINGDOM KINGDOM KINGDOM Coca-Cola HBC AG 0.37 UNITED National Grid 2.37 UNITED Standard Chartered 0.85 UNITED KINGDOM KINGDOM KINGDOM Compass Group 1.96 UNITED Natwest Group 0.77 UNITED Tesco 1.23 UNITED KINGDOM KINGDOM KINGDOM CRH 2.08 UNITED Next 0.72 UNITED Unilever 7.99 UNITED KINGDOM KINGDOM
    [Show full text]
  • Constituents & Weights
    2 FTSE Russell Publications 19 August 2021 FTSE 100 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.59 UNITED GlaxoSmithKline 3.7 UNITED RELX 1.88 UNITED KINGDOM KINGDOM KINGDOM Admiral Group 0.35 UNITED Glencore 1.97 UNITED Rentokil Initial 0.49 UNITED KINGDOM KINGDOM KINGDOM Anglo American 1.86 UNITED Halma 0.54 UNITED Rightmove 0.29 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.26 UNITED Hargreaves Lansdown 0.32 UNITED Rio Tinto 3.41 UNITED KINGDOM KINGDOM KINGDOM Ashtead Group 1.26 UNITED Hikma Pharmaceuticals 0.22 UNITED Rolls-Royce Holdings 0.39 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.41 UNITED HSBC Hldgs 4.5 UNITED Royal Dutch Shell A 3.13 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 6.02 UNITED Imperial Brands 0.77 UNITED Royal Dutch Shell B 2.74 UNITED KINGDOM KINGDOM KINGDOM Auto Trader Group 0.32 UNITED Informa 0.4 UNITED Royal Mail 0.28 UNITED KINGDOM KINGDOM KINGDOM Avast 0.14 UNITED InterContinental Hotels Group 0.46 UNITED Sage Group 0.39 UNITED KINGDOM KINGDOM KINGDOM Aveva Group 0.23 UNITED Intermediate Capital Group 0.31 UNITED Sainsbury (J) 0.24 UNITED KINGDOM KINGDOM KINGDOM Aviva 0.84 UNITED International Consolidated Airlines 0.34 UNITED Schroders 0.21 UNITED KINGDOM Group KINGDOM KINGDOM B&M European Value Retail 0.27 UNITED Intertek Group 0.47 UNITED Scottish Mortgage Inv Tst 1 UNITED KINGDOM KINGDOM KINGDOM BAE Systems 0.89 UNITED ITV 0.25 UNITED Segro 0.69 UNITED KINGDOM
    [Show full text]
  • News Precious Metals News
    ® ® Precious® Metals News A Publication of the International Precious Metals Institute ® (850) 476-1156 • Fax (850) 476-1548 • E-mail: [email protected] • www.ipmi.org Volume 42, Number 5 May 2018 IPMI 6th Annual Platinum Dinner The IPMI’s 6th Annual Platinum Dinner will again be held at Other sponsorship available the historic and elegant Lotte Palace New York Hotel on Madison Drink Sponsor- have your owned named drink at the Plati- Avenue in Manhattan Thursday September 13. Guest speaker will num Dinner Cocktail hour! Also includes sponsor banner. Call IPMI be Derek Sammann of the CME Group. You can register for your office for details. 850-476-1156 table or seat online on our website www.ipmi.org under Event We hope to see you at the Palace in September! Calendar. Platinum, Silver and Gold Sponsored Tables are again offered as well as single seats. • Platinum Sponsored Tables are for 10 guests of the Spon- sor and includes table signage as well as company name on sponsor banner. All guests of sponsor receive one year membership in IPMI provided they do not already have a membership. $5350.00 • Gold Sponsorship includes 4 dinner seats and table signage as well as company name on sponsor banner. $2500.00 • Silver Sponsorship includes 2 dinner seats and table signage as well as company name on sponsor banner. $1400.00 • Single seat for member $375.00 Non Member or those not cur- rent on dues $425.00 (includes a one year membership) Derek Sammann to IPMIbe 6th Annual Featured Platinum Dinner Speaker at IPMI’s 6th Annual Platinum Dinner The IPMI’s 6th Annual Platinum Dinner will again be held at the historic and elegant Lotte Palace New The IPMI’s 6th An- as Managing Director, Global Head of Foreign Exchange.
    [Show full text]
  • Xs0179407910.Pdf
    HSBC Bank Capital Funding (Sterling 1) L.P. (established in Jersey as a limited partnership under the Limited Partnerships (Jersey) Law 1994) £700,000,000 5.844% Non-cumulative Step-up Perpetual Preferred Securities having the benefit of a subordinated guarantee of HSBC Bank plc (incorporated with limited liability under the laws of England and Wales with registered number 14259) Issue Price: £1,000 per Preferred Security The £700,000,000 5.844% Non-cumulative Step-up Perpetual Preferred Securities, (the ‘‘Preferred Securities’’) each issued for a capital contribution of £1,000 (referred to herein as the ‘‘nominal amount’’), representing limited partnership interests in HSBC Bank Capital Funding (Sterling 1) L.P., (the ‘‘Issuer’’), will be issued on 5 November 2003 (the ‘‘Issue Date’’). The Preferred Securities will entitle investors, subject to certain conditions described herein, to receive non-cumulative cash distributions (‘‘Distributions’’) annually in arrear on 5 November in each year until 5 November 2031 and thereafter semi-annually in arrear on 5 May and 5 November in each year. Distributions shall accrue from (and including) the Issue Date to (but excluding) 5 November 2031 at a fixed rate per annum of 5.844% and semi-annually in arrear from (and including) 5 November 2031, at a floating rate per annum equal to the sum of 1.76% and six-month LIBOR for the relevant Distribution Period (as defined herein). The first Distribution will, if payable, be paid on 5 November 2004, and will be calculated in respect of the period from (and including) 5 November 2003 to (but excluding) 5 November 2004).
    [Show full text]